The IL6 role in NASH is controversial since it was postulated that is a key factor in the progression of this disease and the development of IR [59] and other researchers have assumed that IL6 may limit endotoxemia and obesity-associated IR [60]. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.